Meso-2,3-Dimercaptosuccinic Acid in the Diagnosis and Treatment of Lead Poisoning

References

• Annest J. L., Pirkle J. L., Hakuc D., Neese J. W., Bayse D. D., Kovar M. G. Chronological trend in blood lead levels between 1978 and 1980. N. Engl. J. Med. 1983; 308: 1373–1377
   PubMed Web of Science ®Google Scholar
• Piomelli S., Rosen J. F., Chisolm J. J., Jr., Graef J. W. Management of childhood lead poisoning. J. Pediatr. 1934; 105: 523–532
   Google Scholar
• Chelating Agents and Some Drug Antagonists. Martindale The Extra‐Pharmacopeia28th ed, J. E.F. Reynolds, A. B. Prasad. The Pharmaceutical Press, London 1982; 382–389
   Google Scholar
• Aposhian H. V. DMSA and DMPS‐water soluble antidotes for heavy metal poisoning. Ann. Rev. Pharmacol. Toxicol. 1983; 23: 193–215
   PubMed Web of Science ®Google Scholar
• Altkes I., Teitelbaum D., Kadushin F., Lampert K., Hopkins R., Ryan J. Lead poisoning in a capacitor and resistant plant ‐ Colorado. MMWR 1985; 34: 384–385
   PubMedGoogle Scholar
• Stokinger H. E. The Hetals. Patty's Industrial Hygiene and Toxicology, vol. 2A Toxicology3rd ed, G. D. Clayton, F. E. Clayton. John Wiley & Sons Inc., New York 1981; 1687–1728
   Google Scholar
• Wedeen R. P., Maesaka J. K., Weiner B., Lipat G. A., Lyons M. M., Vitale L. F., Joselow M. M. Occupational lead nephropathy. Am. J. Med. 1975; 59: 630–641
   PubMed Web of Science ®Google Scholar
• Lauwerys R. S. Occupational Toxicology. Casarett and Doull's Toxicology, the Basic Science of Poisons2nd ed., J. Doull, C. D. Klaassen, M. O. amdur. MacMillan publishing Co., Inc. 1980; 705
   Google Scholar
• Hershko C., Abrahamov A., Moreb J., Hersh M., Shiffman R., Shahin A., Richter E. D., Konijn A. M., Weisenberg E., Graver F., Avni A., Shahin S., Eisenberg A., Yaffe Y. Lead poisoning in a west bank village. Arch. Intern. Med. 1984; 144: 1969–1973
   PubMed Web of Science ®Google Scholar
• Markowitz M. E., Rosen J. F. Assessment of lead stores in children: validation of an 8‐hour CaNa2 EDTA provocative test. J. Pediatr. 1984; 104: 337–341
   PubMed Web of Science ®Google Scholar
• Prerovska I., Teisinger J. Excretion of lead and its biological activity several years after termination of exposure. Brit. J. Industr. Med. 1970; 27: 352–355
   PubMedGoogle Scholar
• Friedheim E., Graziano J. H., Popovac D., Dragovic D., Kaul B. Treatment of lead poisoning by 2,3‐dimercaptosuccinic acid. Lancet 1978; 2: 1234–1236
   PubMed Web of Science ®Google Scholar
• Fernandez F. D. Micromethod for lead determination in whole blood by atomic absorption with use of the graphite furnace. Clin. Chem. 1975; 21: 558–561
   PubMed Web of Science ®Google Scholar
• Lenz K., Hruby K., Druml W., Eder A., Gaszner A., Kleinberger G., Pichler M., Weiser M. 2,3‐dimercaptosuccinic acid in human arsenic poisoning. Arch. Toxicol. 1981; 47: 241–243
   PubMed Web of Science ®Google Scholar
• Tadlock C. H., Aposhian H. V. Protection of mice against the lethal effects of sodium arsenite by 2,3‐dimercapto‐1‐propane‐sulfonic acid and dimercaptosuccinic acid. Biochem. Biophy. Res. Commun. 1980; 94: 501–507
   PubMed Web of Science ®Google Scholar
• Aposhian H. V., Tadlock C. H., Moon T. E. Protection of mice against the lethal effects of sodium arsenite ‐ a quantitative comparison of a number of chelating agents. Toxicol. Appl. Pharmacol. 1981; 61: 385–392
   PubMed Web of Science ®Google Scholar
• Graziano J. H., Cuccia D., Friedheim E. The pharmacology of 2,3‐dimercaptosuccinic acid and its potential use in arsenic poisoning. J. Pharmacol. Exp. Ther. 1978; 207: 1051–1055
   PubMed Web of Science ®Google Scholar
• Friedheim E., Corvi C., Wakker C. H. Meso‐dimercaptosuccinic acid a chelating agent for the treatment of mercury and lead poisoning. J. Pharm. Pharmacol. 1976; 28: 711–712
   PubMed Web of Science ®Google Scholar
• Graziano J. H., Leong J. K., Freidheim E. 2,3‐dimercaptosuccinic acid: a new agent for the treatment of lead poisoning. J. Pharmacol. Exp. Ther. 1978; 206: 696–700
   PubMed Web of Science ®Google Scholar
• Devars Du Mayne J. F., Prevost C., Gaudin B., Languille M., Cerf M., Nordmann Y. Saturnisme traite par l'acide 2,3‐dimercaptosuccinique. Press Med. 1984; 13: 2209
   PubMedGoogle Scholar
• Graziano J. H., Siris E. S., LoIacono H., Silverberg S. J., Turgeon L. 2,3‐dimercaptosuccinic acid as an antidote for lead intoxication. Clin. Pharmacol. Ther. 1985; 37: 431–438
   PubMed Web of Science ®Google Scholar
• Friedheim E., Corvi C. Meso‐dimercaptosuccinic acid, a chelating agent for the treatment of mercury poisoning. J. Pharm. Pharmacol. 1975; 27: 624–626
   PubMed Web of Science ®Google Scholar
• Magos L. The effects of dimercaptosuccinic acid on the excretion and distribution of mercury in rats and mice treated with mercuric chloride and methyl‐mercury chloride. Br. J. Pharmacol. 1976; 56: 479–484
   PubMed Web of Science ®Google Scholar
• Aaseth J., Friedheim E. A.H. Treatment of methyl mercury poisoning in mice with 2,3‐dimercuptosuccinic acid and other complexing thiols. Acta. Pharmacol. Toxicol. 1978; 42: 248–252
   PubMedGoogle Scholar
• Kostynisk P. J. Mobilization and removal of methyl‐mercury in the dog during extracorporeal complexing hemodialysis with 2,3‐dimercaptosuccinic acid (DMSA). J. Pharmacol. Exp. Ther. 1982; 221: 63–68
   PubMed Web of Science ®Google Scholar
• Zvirblis P., Ellin R. I. Acute systemic toxicity of pure dimercaprol and trimercaptopropane. Toxicol. Appl. Pharmacol. 1976; 36: 297–299
   PubMed Web of Science ®Google Scholar
• Cantilena L. R., Klaassen C. D. The effect of chelating agents on the excretion of endogenous metals. Toxicol. Appl. Pharmacol. 1982; 63: 344–350
   PubMed Web of Science ®Google Scholar
• Kawamura J., Hosokawa S., Yoshida O., Fujita T., Ishii Y., Torizuka K. Validity of 99mTc diwercaptosuccinic acid renal uptake for an assessment of individual kidney function. J. Urol. 1978; 199: 305–309
   Google Scholar
• Wang S. C., Ting K. S., Wu C. C. Chelating therapy with NaDMS in occupational lead and mercury intoxication. Chin. Med. J. 1965; 84: 437–439
   PubMed Web of Science ®Google Scholar